Skip to main content

An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study

Abstract

Introduction

Despite the high prevalence of asthenia in cancer patients, around 50–75%, and its impact on quality of life, it continues to be a difficult symptom to assess and manage. This study defines the extent of perception and diagnosis of asthenia associated with cancer among Spanish oncologists.

Methods

A descriptive, observational study conducted in Spain based on a five-part structured questionnaire available to participants through a private website.

Results

The 100 oncologists surveyed, most in the public healthcare setting, diagnose asthenia in 58–70% of cases. They consider old age (56.5%) and advanced-stage disease (94.2%) as factors associated with the occurrence of asthenia, which is also common in, particularly, tumours, such as pancreatic cancer (30.4%), and some therapies, notably chemotherapy alone (67%) or combined with radiotherapy (96%). Despite its adequate detection, physicians rarely ask their patients about asthenia, use instruments for its evaluation or assess its impact on quality of life. Likewise, only 40% of all patients are treated, although therapeutic intervention, a multidisciplinary approach combining drug and non-drug treatments and managing a variety of causative factors, can be considered adequate. Finally, 91.5% of those surveyed do not have action guidelines for asthenia in their hospitals.

Conclusions

Even when asthenia is widely diagnosed in cancer patients in Spain, there is a laxity in its assessment and treatment. Increased awareness among healthcare professionals of its impact and relevance is therefore required, as well as adequate protocols for its systematic detection and management within the routine assessment and treatment of cancer patients.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Andreu M, Lizon J (2004) Concepto y etiopatogenia de la astenia. In: González-Barón M, Ordóñez A (eds) La astenia tumoral. Editorial Médica Panamericana, Madrid, pp 1–9

    Google Scholar 

  2. 2.

    Belda-Iniesta C, De Castro J, Fresno JA et al (2004) Bases biológicas de la astenia asociada al cáncer. In: González-Barón M, Ordóñez A (eds) La astenia tumoral. Editorial Médica Panamericana, Madrid, pp 23–47

  3. 3.

    Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34[3 Suppl 2]:4–12

    CAS  Google Scholar 

  4. 4.

    Stone P, Ream E, Richardson A et al (2003) Cancer-related fatigue-a difference of opinion? Results of a multicentre survey of healthcare professionals, patients and caregivers. Eur J Cancer Care (Engl) 12:20–27

    Article  CAS  Google Scholar 

  5. 5.

    Stone P, Richardson A, Ream E et al (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 11:971–975

    CAS  Google Scholar 

  6. 6.

    Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801

    PubMed  Article  Google Scholar 

  7. 7.

    Curt GA, Breitbart W, Cella D et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    La Verde G, Arienti D (2002) “Fatigue” e sintomi correlati in emato-oncologia: la visione dell’ematologo e del paziente. Recenti Prog Med 93:463–469

    PubMed  Google Scholar 

  9. 9.

    Kurtz ME, Kurtz JC, Given CC, Given B (1996) Concordance of cancer patient and caregiver symptom reports. Cancer Pract 4:185–190

    PubMed  CAS  Google Scholar 

  10. 10.

    Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A (1998) How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 83:1640–1651

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Patrick DL, Ferketich SL, Frame PS et al (2003) National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15–17, 2002. J Natl Cancer Inst 95:1110–1117

    PubMed  Article  Google Scholar 

  12. 12.

    Forlenza MJ, Hall P, Lichtenstein P et al (2005) Epidemiology of cancer-related fatigue in the Swedish twin registry. Cancer. 104:2022–2031

    PubMed  Article  Google Scholar 

  13. 13.

    Schmidt CF, Bestmann B, Kuchler T et al (2005) Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World J Surg 29:1630–1641

    PubMed  Article  Google Scholar 

  14. 14.

    Respini D, Jacobsen PB, Thors C et al (2003) The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47:273–279

    PubMed  Article  Google Scholar 

  15. 15.

    Bower JE, Ganz PA, Desmond KA et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106:751–758

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Manuel González Barón.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Barón, M.G., Feyjóo, M., Álvarez, Y.E. et al. An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study. Clin Transl Oncol 10, 288–293 (2008). https://doi.org/10.1007/s12094-008-0199-4

Download citation

Keywords

  • Asthenia
  • Fatigue
  • Neoplasm
  • Questionnaire
  • Medical oncology